Literature DB >> 16698992

Inhibition of the NF-kappaB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo.

Jeremy O Jones1, Ann M Arvin.   

Abstract

Varicella-zoster virus (VZV) is an alphaherpesvirus that causes varicella and herpes zoster. Using human cellular DNA microarrays, we found that many nuclear factor kappa B (NF-kappaB)-responsive genes were down-regulated in VZV-infected fibroblasts, suggesting that VZV infection inhibited the NF-kappaB pathway. The activation of this pathway causes a cellular antiviral response, including the production of alpha/beta interferon, cytokines, and other proteins that restrict viral infection. In these experiments, we demonstrated that VZV interferes with NF-kappaB activation in cultured fibroblasts and in differentiated epidermal cells in skin xenografts of SCIDhu mice infected in vivo. VZV infection of fibroblasts caused a transient nuclear translocation of p50 and p65, the canonical NF-kappaB family members. In a process that was dependent upon the presence of infectious VZV, these proteins rapidly became sequestered in the cytoplasm of VZV-infected cells. Exclusion of NF-kappaB proteins from nuclei was associated with the continued presence of IkappaBalpha, which binds p50 and p65 and prevents their nuclear accumulation. IkappaBalpha levels did not diminish even though the protein became phosphorylated and ubiquitinated, as determined based on detection of the characteristic high-molecular-weight form of the protein, and the 26S proteasome remained functional in VZV-infected cells. VZV infection also inhibited the characteristic degradation of IkappaBalpha that is induced by exposure of fibroblasts to tumor necrosis factor alpha. As expected, herpes simplex virus 1 caused the persistent nuclear translocation of NF-kappaB proteins, which has been shown to facilitate its replication, whereas VZV infection progressed without persistent NF-kappaB nuclear localization. We suggest that VZV has evolved a mechanism to limit host cell antiviral defenses by sequestering NF-kappaB proteins in the cytoplasm, a strategy that appears to be unique among the herpesviruses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16698992      PMCID: PMC1472140          DOI: 10.1128/JVI.01956-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication.

Authors:  Karen L Mossman; James R Smiley
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.

Authors:  S Bour; C Perrin; H Akari; K Strebel
Journal:  J Biol Chem       Date:  2001-02-16       Impact factor: 5.157

3.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Expression of TNF-alpha by herpes simplex virus-infected macrophages is regulated by a dual mechanism: transcriptional regulation by NF-kappa B and activating transcription factor 2/Jun and translational regulation through the AU-rich region of the 3' untranslated region.

Authors:  S R Paludan; S Ellermann-Eriksen; V Kruys; S C Mogensen
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

5.  Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation.

Authors:  K L Oie; D J Pickup
Journal:  Virology       Date:  2001-09-15       Impact factor: 3.616

Review 6.  Activation and inhibition of virus and interferon: the herpesvirus story.

Authors:  Karen L Mossman
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

7.  Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.

Authors:  C Amici; G Belardo; A Rossi; M G Santoro
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

8.  Herpes simplex virus type 2 induces secretion of IL-12 by macrophages through a mechanism involving NF-kappaB.

Authors:  Lene Malmgaard; Søren R Paludan; Søren C Mogensen; Svend Ellermann-Eriksen
Journal:  J Gen Virol       Date:  2000-12       Impact factor: 3.891

9.  The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.

Authors:  Li Liu; Michael T Eby; Nisha Rathore; Suwan K Sinha; Arvind Kumar; Preet M Chaudhary
Journal:  J Biol Chem       Date:  2002-02-05       Impact factor: 5.157

10.  Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.

Authors:  Jennifer Moffat; Hideki Ito; Marvin Sommer; Shannon Taylor; Ann M Arvin
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  27 in total

Review 1.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

Review 2.  Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Authors:  Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis.

Authors:  Nandini Sen; Xibing Che; Jaya Rajamani; Leigh Zerboni; Phillip Sung; Jason Ptacek; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-21       Impact factor: 11.205

Review 4.  Varicella zoster virus immune evasion strategies.

Authors:  Allison Abendroth; Paul R Kinchington; Barry Slobedman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation.

Authors:  Kezhen Wang; Liwen Ni; Shuai Wang; Chunfu Zheng
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

6.  Cellular transcriptome analysis reveals differential expression of pro- and antiapoptosis genes by varicella-zoster virus-infected neurons and fibroblasts.

Authors:  Amos Markus; Hiba Waldman Ben-Asher; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

7.  Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promoters.

Authors:  Nadia El Mjiyad; Sébastien Bontems; Geoffrey Gloire; Julie Horion; Patricia Vandevenne; Emmanuel Dejardin; Jacques Piette; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

8.  The phosphorylation profile of protein kinase A substrates is modulated during Varicella-zoster virus infection.

Authors:  Nathalie Desloges; Markus Rahaus; Manfred H Wolff
Journal:  Med Microbiol Immunol       Date:  2007-12-08       Impact factor: 3.402

9.  Post varicella hepatic actinomycosis in a 5-year-old girl mimicking acute abdomen.

Authors:  Ahmet Guven; Vural Kesik; M Salih Deveci; M Sahin Ugurel; Haluk Ozturk; Vedat Koseoglu
Journal:  Eur J Pediatr       Date:  2007-12-06       Impact factor: 3.183

10.  Varicella-zoster virus infection induces the secretion of interleukin-8.

Authors:  Nathalie Desloges; Christiane Schubert; Manfred H Wolff; Markus Rahaus
Journal:  Med Microbiol Immunol       Date:  2007-10-02       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.